RecruitingNCT04329234
Korean Heart Failure Registry III
Korean Heart Failure Registry Ⅲ of Korean Society of Heart Failure
Sponsor
Seoul National University Bundang Hospital
Enrollment
10,000 participants
Start Date
Oct 1, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
KorHF III is a multi-center, nationwide, prospective registry of the Korean Society of Heart Failure, which enrolls patients with acute heart failure in Korea. The aim of this registry is to analyze the etiology, treatment, treatment, and prognosis to develop strategies for managing acute heart failure.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- All consecutive hospitalized adult heart failure patients who fulfill one of 1-3 and 4
- Symptoms of heart failure
- Signs of heart failure
- Lung congestion in Chest-x-ray
- Objective finding of structural and/or functional disorder of the heart or elevated natriuretic peptide levels
Exclusion Criteria2
- Patients younger than 18 years old
- Patients who do no consent
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04329234
Related Trials
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
NCT0600819780 locations
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
NCT0539276469 locations
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
NCT0739765021 locations
Oxygen Targets in Acute Heart Failure With Pulmonary Congestion
NCT056132182 locations
a PRagmatic Observational Study of Congestion proFILes in patiEnts With Acute Heart Failure
NCT065878541 location